
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (07): 831-837.DOI: 10.12114/j.issn.1007-9572.2023.0887
Special Issue: 肥胖/减重最新文章合辑
• Original Research • Previous Articles Next Articles
Received:2024-02-19
Revised:2024-07-24
Published:2025-03-05
Online:2025-01-23
Contact:
WANG Weiqiang
通讯作者:
王为强
作者简介:作者贡献:
顾可羿提出研究理念,负责数据收集、数据整理、统计分析、论文撰写;潘姚佳负责数据整理、协助编辑与修改、统计分析;韩正负责统计分析、论文完善;付晓雅、顾翰东、杨菲负责数据收集、数据整理、论文完善;王为强负责最终版本修订,进行项目管理、思路指导、提供资源,对文章监督管理和审查,对文章整体负责。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0887
| 组别 | 人数 | 性别(男/女) | 当前吸烟[名(%)] | 当前饮酒[名(%)] | 大专及以上[名(%)] | 年龄( | BMI ( | WC ( | SBP ( | DBP ( |
|---|---|---|---|---|---|---|---|---|---|---|
| MHNO组 | 281 | 112/169 | 36(12.8) | 28(10.0) | 90(32.0) | 30.2±8.8 | 21.88±1.74 | 75.48±11.48 | 120±12 | 77±9 |
| MHO组 | 112 | 51/61 | 21(18.8) | 19(17.0) | 13(11.6) | 31.9±7.9 | 27.71±2.66a | 86.55±13.73a | 126±15a | 82±11a |
| MUNO组 | 69 | 43/26 | 15(21.7) | 18(26.1) | 7(10.1) | 33.9±7.2a | 23.17±1.67ab | 84.72±18.17a | 131±13a | 87±8ab |
| MUO组 | 160 | 112/48 | 43(26.9) | 30(18.8) | 21(13.1) | 34.3±7.6a | 29.21±3.27ab | 93.02±10.90ab | 140±15ab | 92±11ab |
| F(χ2)值 | 41.950c | 13.966c | 14.097c | 48.673c | 10.276 | 336.714 | 87.332 | 70.469 | 75.366 | |
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
| 组别 | baPWV ( | TC ( | TG ( | HDL-C( | LDL-C ( | FPG ( | Scr ( | SUA ( | SUA/Cr ( | |
| MHNO组 | 1 110.03±149.29 | 4.29±0.70 | 0.96±0.43 | 1.46±0.29 | 2.58±0.63 | 5.00±0.39 | 62.28±12.33 | 277.56±77.63 | 4.47±0.95 | |
| MHO组 | 1 183.54±175.39a | 4.36±0.81 | 1.11±0.48 | 1.34±0.26a | 2.71±0.74a | 5.14±0.34 | 62.38±12.97 | 302.94±82.80a | 4.88±1.05a | |
| MUNO组 | 1 239.61±173.70a | 4.95±1.03ab | 2.04±1.28ab | 1.20±0.29ab | 3.06±0.91ab | 5.95±2.08ab | 66.03±13.11 | 320.8±76.85a | 4.91±1.03a | |
| MUO组 | 1 305.58±205.38ab | 4.93±0.96ab | 2.85±2.18ab | 1.07±0.22ab | 2.98±0.85ab | 6.21±2.06ab | 66.63±13.00ab | 358.31±93.41ab | 5.45±1.30ab | |
| F(χ2)值 | 41.996 | 24.083 | 54.272 | 87.817 | 13.180 | 24.959 | 5.137 | 29.806 | 24.490 | |
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.002 | <0.001 | <0.001 |
Table 1 Comparison of basic clinical characteristics of different metabolic phenotypes of obesity
| 组别 | 人数 | 性别(男/女) | 当前吸烟[名(%)] | 当前饮酒[名(%)] | 大专及以上[名(%)] | 年龄( | BMI ( | WC ( | SBP ( | DBP ( |
|---|---|---|---|---|---|---|---|---|---|---|
| MHNO组 | 281 | 112/169 | 36(12.8) | 28(10.0) | 90(32.0) | 30.2±8.8 | 21.88±1.74 | 75.48±11.48 | 120±12 | 77±9 |
| MHO组 | 112 | 51/61 | 21(18.8) | 19(17.0) | 13(11.6) | 31.9±7.9 | 27.71±2.66a | 86.55±13.73a | 126±15a | 82±11a |
| MUNO组 | 69 | 43/26 | 15(21.7) | 18(26.1) | 7(10.1) | 33.9±7.2a | 23.17±1.67ab | 84.72±18.17a | 131±13a | 87±8ab |
| MUO组 | 160 | 112/48 | 43(26.9) | 30(18.8) | 21(13.1) | 34.3±7.6a | 29.21±3.27ab | 93.02±10.90ab | 140±15ab | 92±11ab |
| F(χ2)值 | 41.950c | 13.966c | 14.097c | 48.673c | 10.276 | 336.714 | 87.332 | 70.469 | 75.366 | |
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
| 组别 | baPWV ( | TC ( | TG ( | HDL-C( | LDL-C ( | FPG ( | Scr ( | SUA ( | SUA/Cr ( | |
| MHNO组 | 1 110.03±149.29 | 4.29±0.70 | 0.96±0.43 | 1.46±0.29 | 2.58±0.63 | 5.00±0.39 | 62.28±12.33 | 277.56±77.63 | 4.47±0.95 | |
| MHO组 | 1 183.54±175.39a | 4.36±0.81 | 1.11±0.48 | 1.34±0.26a | 2.71±0.74a | 5.14±0.34 | 62.38±12.97 | 302.94±82.80a | 4.88±1.05a | |
| MUNO组 | 1 239.61±173.70a | 4.95±1.03ab | 2.04±1.28ab | 1.20±0.29ab | 3.06±0.91ab | 5.95±2.08ab | 66.03±13.11 | 320.8±76.85a | 4.91±1.03a | |
| MUO组 | 1 305.58±205.38ab | 4.93±0.96ab | 2.85±2.18ab | 1.07±0.22ab | 2.98±0.85ab | 6.21±2.06ab | 66.63±13.00ab | 358.31±93.41ab | 5.45±1.30ab | |
| F(χ2)值 | 41.996 | 24.083 | 54.272 | 87.817 | 13.180 | 24.959 | 5.137 | 29.806 | 24.490 | |
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.002 | <0.001 | <0.001 |
| 变量 | SUA | baPWV | ||
|---|---|---|---|---|
| r值 | P值 | r值 | P值 | |
| 腰围 | 0.274 | <0.001 | 0.280 | <0.001 |
| BMI | 0.341 | <0.001 | 0.339 | <0.001 |
| SBP | 0.356 | <0.001 | 0.576 | <0.001 |
| DBP | 0.299 | <0.001 | 0.619 | <0.001 |
| FPG | 0.087 | 0.030 | 0.280 | <0.001 |
| HDL-C | -0.359 | <0.001 | -0.204 | <0.001 |
| LDL-C | 0.214 | <0.001 | 0.222 | <0.001 |
| TG | 0.313 | <0.001 | 0.270 | <0.001 |
| TC | 0.226 | <0.001 | 0.284 | <0.001 |
| SUA | — | — | 0.189 | <0.001 |
| SUA/Cr | 0.714 | <0.001 | 0.088 | 0.029 |
| baPWV | 0.189 | <0.001 | — | — |
Table 2 Correlation between SUA and baPWV and various clinical indicators
| 变量 | SUA | baPWV | ||
|---|---|---|---|---|
| r值 | P值 | r值 | P值 | |
| 腰围 | 0.274 | <0.001 | 0.280 | <0.001 |
| BMI | 0.341 | <0.001 | 0.339 | <0.001 |
| SBP | 0.356 | <0.001 | 0.576 | <0.001 |
| DBP | 0.299 | <0.001 | 0.619 | <0.001 |
| FPG | 0.087 | 0.030 | 0.280 | <0.001 |
| HDL-C | -0.359 | <0.001 | -0.204 | <0.001 |
| LDL-C | 0.214 | <0.001 | 0.222 | <0.001 |
| TG | 0.313 | <0.001 | 0.270 | <0.001 |
| TC | 0.226 | <0.001 | 0.284 | <0.001 |
| SUA | — | — | 0.189 | <0.001 |
| SUA/Cr | 0.714 | <0.001 | 0.088 | 0.029 |
| baPWV | 0.189 | <0.001 | — | — |
| 因变量 | MHO | MUNO | MUO | |||
|---|---|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
| 高baPWV | ||||||
| 模型1 | 2.673(1.124~6.358) | 0.026 | 4.160(1.689~10.248) | 0.002 | 10.209(5.109~20.400) | <0.001 |
| 模型2 | 2.477(1.034~5.933) | 0.042 | 3.325(1.327~8.334) | 0.010 | 7.967(3.895~16.296) | <0.001 |
| 模型3 | 2.868(1.175~6.998) | 0.021 | 3.859(1.500~9.923) | 0.005 | 8.958(4.287~18.721) | <0.001 |
| 高尿酸血症 | ||||||
| 模型1 | 2.657(1.074~6.572) | 0.034 | 3.060(1.121~8.355) | 0.029 | 9.960(4.841~20.491) | <0.001 |
| 模型2 | 2.899(1.116~7.482) | 0.029 | 3.036(1.048~8.797) | 0.041 | 10.091(4.535~22.455) | <0.001 |
| 模型3 | 3.129(1.179~8.299) | 0.022 | 3.301(1.107~9.849) | 0.032 | 9.958(4.357~22.756) | <0.001 |
Table 3 Multifactorial Logistic regression analysis of the effect of obesity metabolic phenotype on high baPWV and hyperuricaemia
| 因变量 | MHO | MUNO | MUO | |||
|---|---|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
| 高baPWV | ||||||
| 模型1 | 2.673(1.124~6.358) | 0.026 | 4.160(1.689~10.248) | 0.002 | 10.209(5.109~20.400) | <0.001 |
| 模型2 | 2.477(1.034~5.933) | 0.042 | 3.325(1.327~8.334) | 0.010 | 7.967(3.895~16.296) | <0.001 |
| 模型3 | 2.868(1.175~6.998) | 0.021 | 3.859(1.500~9.923) | 0.005 | 8.958(4.287~18.721) | <0.001 |
| 高尿酸血症 | ||||||
| 模型1 | 2.657(1.074~6.572) | 0.034 | 3.060(1.121~8.355) | 0.029 | 9.960(4.841~20.491) | <0.001 |
| 模型2 | 2.899(1.116~7.482) | 0.029 | 3.036(1.048~8.797) | 0.041 | 10.091(4.535~22.455) | <0.001 |
| 模型3 | 3.129(1.179~8.299) | 0.022 | 3.301(1.107~9.849) | 0.032 | 9.958(4.357~22.756) | <0.001 |
| [1] |
马依彤,刘帅. 肥胖与心血管疾病的研究进展[J]. 新疆医科大学学报,2021,44(10):1111-1113.
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
辛保凤,黄定. 肱踝脉搏波传导速度(baPWV)的研究进展 [J]. 世界最新医学信息文摘,2019,19(12):59-61.
|
| [18] |
方宁远,吕力为,吕晓希,等. 中国高尿酸血症相关疾病诊疗多学科专家共识(2023年版)[J]. 中国实用内科杂志,2023,43(06):461-80. DOI:10.19538/j.nk2023060106.
|
| [19] |
米杰,王天有,腾红红,等. 北京市儿童青少年肥胖及代谢综合征表型患病率、影响因素和流行特征:北京儿童青少年代谢综合征(BCAMS)项目流行病学调查结果//中华医学会第十四次全国儿科学术会议[C].南宁,2006 .
|
| [20] |
|
| [21] |
王庭俊,张玲玉,卢丹,等. 中青年和老年代谢健康型肥胖与动脉僵硬度关系的差异[J]. 中华高血压杂志,2023,31(7):633-641. DOI:10.16439/j.issn.1673-7245.2023.07.007.
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
黄敏钢. 中国东北农村人群血清尿酸/肌酐比值与代谢综合征及其组分的关系[D]. 沈阳:中国医科大学,2022.
|
| [1] | SUN Xiuqin, FENG Zhenlong, WEI Lanxuan, ZENG Yuxin, LIU Jinbo, MA Lin, AN Zhantian, WANG Hongyu. Analysis of the Current Status of Metabolic Syndrome among Middle-aged and Elderly People in Shijingshan District, Beijing, and Its Behavioral and Lifestyle Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4424-4430. |
| [2] | JIANG Chen, AN Ni, XU Yunjing, NIU Shaona, LI Fengming, JIANG Liangmei. A Cross-sectional Study of Hospitalization Characteristics and Healthcare Resource Consumption of Patients with Cardiovascular-kidney-metabolic Syndrome [J]. Chinese General Practice, 2026, 29(28): 4172-4178. |
| [3] | LIU Zhenyu, WANG Wendong, YAO Qing, WANG Jiangmin, CAO Wendong. Analysis of Prevalence and Influencing Factors of Cardiovascular-kidney-metabolic Syndrome among Adults in Haidian District, Beijing [J]. Chinese General Practice, 2026, 29(27): 3969-3975. |
| [4] | ZHANG Ji, LI Ling, ZHOU Jie, WU Yanli, JI Wei, LIU Tao. A Prospective Cohort Study on Relationship between Lipid Accumulation Product and Incidence of Metabolic Syndrome in Adults [J]. Chinese General Practice, 2026, 29(22): 3138-3145. |
| [5] | JIAN Yingchun, ZENG Yongqin, ZHANG Haiping, WANG Zhengdi, AN Ke, YAN Rui. Recent Advances in Mitochondrial Dysfunction in Chronic Metabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2577-2584. |
| [6] | ZHANG Mei, LI Mengqi, LU Shuangyan, PU Huijie, LI Guitao, DIAO Yi, TAO Hui, FAN Luming, YE Aifang, MAO Yong. Association between the Ratio of Uric Acid to High-density Lipoprotein Cholesterol and Metabolic Syndrome in the Yi Ethnic Group of Yunnan Province [J]. Chinese General Practice, 2026, 29(18): 2532-2537. |
| [7] | LIU Daiyue, LIU Xincan, LAN Zhenzhen. Research Progress on Postprandial Hyperlipidemia and Its Therapeutic Approaches [J]. Chinese General Practice, 2026, 29(18): 2546-2553. |
| [8] | ZHANG Xinwen, WEI Guangcheng, ZHANG Xieyu, SHI Jinjie, LI Xiaoxu, MA Rui, YA Yulong, PENG Jiucheng, CAO Wei. The Causal Relationship between Sleep Patterns and Serum Uric Acid: a Bidirectional Mendelian Randomization Study [J]. Chinese General Practice, 2026, 29(17): 2354-2360. |
| [9] | SUN Qinyu, DENG Yifan, YANG Tianxiao, FANG Zhen, JI Jun, HE Shenghu, ZHANG Jing. Clinical Study of HbA1c/ApoA-1, TyG-BMI and Their Combination to Predict the Severity of Coronary Artery Calcification [J]. Chinese General Practice, 2026, 29(09): 1137-1145. |
| [10] | LI Qiuchun, SU Ping, PANG Jinhong, CHEN Qiaoqiao, ZHAO Yingying, HE Ruiyan, WANG Yue, CHEN Xueyu, QIAO Junpeng, CHI Weiwei. Association of Triglyceride Glucose Index with Cardiovascular Disease in Cardiovascular-Kidney-Metabolic Syndrome Stage 0-3 Population: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(09): 1129-1136. |
| [11] | ZHANG Rui, WANG Weiqiang, LU Hongrun, ZHAO Yu, LI Jiazhen. Correlation between the Continuous Metabolic Syndrome Score and Glomerular Filtration Rate in Individuals Aged 60 and Above [J]. Chinese General Practice, 2026, 29(07): 879-884. |
| [12] | LUO Xiu, MA Zhaoli, HUANG Mengyu, REN Qian. A Study of the Causal Effect of Gut Microbiota on Genetic Prediction of Metabolic Syndrome [J]. Chinese General Practice, 2026, 29(05): 612-622. |
| [13] | ZHU Chenrui, LI Na, WU Yuntao, ZHAO Haiyan, HUANG Zhe, LIU Yan, JI Chunpeng, WU Shouling. The Impact of Serum Uric Acid Levels on New-onset Atrioventricular Block: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(05): 583-590. |
| [14] | FENG Zhanpeng, TAN Sijie, GUO Zhen, CAO Liquan. Study on the Isochronous Substitution Effect of 24-hour Activity Behaviors on Metabolic Syndrome in Adolescents [J]. Chinese General Practice, 2026, 29(03): 325-330. |
| [15] | Cardiovascular Internal Medicine Professional Committee of China Medical Education Association, Cardiovascular Health Medicine Branch of China International Exchange and Promotion Association for Medical Care. Expert Consensus on Early Screening and Prevention of Coronary Artery Disease in Young People [J]. Chinese General Practice, 2026, 29(02): 137-147. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||